162 related articles for article (PubMed ID: 3117606)
21. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
Tilton RG; Chang K; Pugliese G; Eades DM; Province MA; Sherman WR; Kilo C; Williamson JR
Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
[TBL] [Abstract][Full Text] [Related]
22. Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane.
Nagata M; Robison WG
Invest Ophthalmol Vis Sci; 1987 Nov; 28(11):1867-9. PubMed ID: 3117719
[TBL] [Abstract][Full Text] [Related]
23. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E; Varagiannis E
Pharmacology; 1985; 31(2):88-96. PubMed ID: 3927328
[TBL] [Abstract][Full Text] [Related]
24. Prefeeding of aldose reductase inhibitor and galactose cataractogenesis.
Unakar NJ; Tsui JY; Johnson MJ
Curr Eye Res; 1989 Oct; 8(10):997-1010. PubMed ID: 2558845
[TBL] [Abstract][Full Text] [Related]
25. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
[No Abstract] [Full Text] [Related]
26. [Morphological classification of the prevention by aldose reductase inhibitor of rat galactosemic cataract].
Akagi Y; Ikebe H; Terubayashi H; Takahashi Y; Tsuji T
Nippon Ganka Gakkai Zasshi; 1989 Apr; 93(4):494-500. PubMed ID: 2508449
[TBL] [Abstract][Full Text] [Related]
27. Galactose-induced retinal microangiopathy in rats.
Kern TS; Engerman RL
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
[TBL] [Abstract][Full Text] [Related]
28. Capillary basement membrane in retina, kidney, and muscle of diabetic dogs and galactosemic dogs and its response to 5 years aldose reductase inhibition.
Engerman RL; Kern TS; Garment MB
J Diabetes Complications; 1993; 7(4):241-5. PubMed ID: 8219367
[TBL] [Abstract][Full Text] [Related]
29. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
[TBL] [Abstract][Full Text] [Related]
30. Sorbinil prevents glomerular hyperperfusion in diabetic rats.
Bank N; Mower P; Aynedjian HS; Wilkes BM; Silverman S
Am J Physiol; 1989 Jun; 256(6 Pt 2):F1000-6. PubMed ID: 2500028
[TBL] [Abstract][Full Text] [Related]
31. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
Frank RN; Amin R; Kennedy A; Hohman TC
Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
[TBL] [Abstract][Full Text] [Related]
32. Diabetes-related histopathologies of the rat retina prevented with an aldose reductase inhibitor.
Robison WG; Tillis TN; Laver N; Kinoshita JH
Exp Eye Res; 1990 Apr; 50(4):355-66. PubMed ID: 2110907
[TBL] [Abstract][Full Text] [Related]
33. Effects of aldose reductase inhibition on the retina and health indices of streptozotocin-diabetic rats.
Kozak WM; Marker NA; Elmer KK
Doc Ophthalmol; 1986; 64(4):355-77. PubMed ID: 2958262
[TBL] [Abstract][Full Text] [Related]
34. [Diabetic changes in pupillary reaction and iridal pathology. No. 1. The role of aldose reductase to the delayed pupillary reaction in galactose-fed rats].
Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
Nippon Ganka Gakkai Zasshi; 1988 Mar; 92(3):484-8. PubMed ID: 3137794
[No Abstract] [Full Text] [Related]
35. Retinal polyol and myo-inositol in galactosemic dogs given an aldose-reductase inhibitor.
Kern TS; Engerman RL
Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3175-7. PubMed ID: 1748548
[TBL] [Abstract][Full Text] [Related]
36. [The role of aldose reductase in diabetic corneal epitheliopathy. Second report: The corneal epithelium of galactosemic rats].
Takahashi Y; Akagi Y; Akimune M; Tamura K; Itoi M
Nippon Ganka Gakkai Zasshi; 1986 Feb; 90(2):336-40. PubMed ID: 3085442
[No Abstract] [Full Text] [Related]
37. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors.
Kador PF; Akagi Y; Takahashi Y; Ikebe H; Wyman M; Kinoshita JH
Arch Ophthalmol; 1990 Sep; 108(9):1301-9. PubMed ID: 2119169
[TBL] [Abstract][Full Text] [Related]
38. Aldose reductase and retinal capillary basement membrane thickening.
Robison WG; Nagata M; Kinoshita JH
Exp Eye Res; 1988 Mar; 46(3):343-8. PubMed ID: 3127228
[TBL] [Abstract][Full Text] [Related]
39. Comparison of aldose reductase inhibitors by determination of IC50 with bovine and rat lens extracts.
Müller P; Hockwin O; Ohrloff C
Ophthalmic Res; 1985; 17(2):115-9. PubMed ID: 3920598
[TBL] [Abstract][Full Text] [Related]
40. [Effect of aldose reductase inhibitor (M79175) on the oscillatory potential in ERG of streptozotocin-fructose induced diabetic rats].
Funada M; Okamoto I; Fujinaga Y; Yamana T
Nippon Ganka Gakkai Zasshi; 1985 Oct; 89(10):1111-9. PubMed ID: 3938182
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
